Article Text

Download PDFPDF

LSO-100 Does early complete remission preclude adverse outcomes in lupus nephritis?
  1. Konstantinos Tselios1,
  2. Dafna Gladman2,
  3. Jiandong Su2 and
  4. Murray Urowitz2
  1. 1Division of Rheumatology, Department of Medicine, McMaster University, Canada
  2. 2Centre for Prognosis Studies in Rheumatic Diseases, Toronto Lupus Clinic, University Health Network, University of Toronto, Canada


Background Early complete remission (within 12 months) is considered an important protective factor against development of chronic kidney disease (CKD) in lupus nephritis (LN). However, a certain proportion of such patients still develop advanced CKD. Our objective was to describe the factors associated with the development of CKD stage IV or worse in LN patients who achieved early complete remission.

Methods Patients with LN based on biopsy or abnormal proteinuria (>0.5g/day) and/or urinary sediment for two consecutive visits in the absence of other plausible explanation were retrieved from the Toronto Lupus Clinic database. Individuals with advanced CKD at baseline (eGFR&x2266;29ml/min/1.73m2) were excluded. All patients achieved complete remission (proteinuria<0.5g/24h, inactive urinary sediment and serum creatinine &x2266;120% of baseline) within 12 months. Patients were followed for at least 5 years after LN diagnosis.

Results Of 273 eligible patients, 21 (7.7%) developed advanced CKD after a median of 5.8 years from the time of remission (range 0.7–31.7 years). At baseline, these patients had higher SCR (124.9±71.9 vs. 80.7±25.8μmol/L, p<0.001); other baseline characteristics were not significantly different. Multivariate survival analysis for predictors of advanced CKD is shown in table 1. The major factors for early CKD were poor compliance or insufficient therapy due to concomitant infections in 7 and moderate-to-severe interstitial fibrosis and tubular atrophy (IFTA) in 4 patients. In late progressors, compliance was poor in 2, moderate-to-severe IFTA in 3, poorly controlled hypertension in 2, thrombotic microangiopathy in one, refractory disease in one while one patient progressed very slowly over 32 years.

Conclusions Patients with impaired kidney function, low complement C3 at baseline and histopathologic features of chronic irreversible damage (interstitial fibrosis/tubular atrophy), are at risk for CKD despite early remission and should be followed closely. The importance of maintenance therapy should be communicated to prevent non-compliance and subsequent flares.

Abstract LSO-100 Table 1

Multivariate survival analysis for predictors of advanced CKD

  • lupus nephritis
  • early remission
  • advanced CKD

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.